---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-308372"
form_type: "8-K"
ticker: "HCA"
cik: "0000860730"
company_name: "HCA Healthcare, Inc."
filed_at: "2022-12-19T23:59:59+00:00"
generated_at: "2026-06-21T02:58:31.803262+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# HCA Healthcare amends bylaws to update director nomination and proxy solicitation requirements

## Summary
- Board adopted Third Amended and Restated Bylaws effective December 19, 2022.
- Amendment revises Article II, Section 11 to require compliance with SEC Rule 14a-19 for director nominations and proxy solicitations.
- Technical, ministerial, and conforming changes made to align with recent Delaware General Corporation Law amendments.

## SEC filing metadata
- accession: 0001193125-22-308372
- form_type: 8-K
- ticker: HCA
- cik: 0000860730
- company_name: HCA Healthcare, Inc.
- filed_at: 2022-12-19T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/860730/000119312522308372/0001193125-22-308372-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/860730/000119312522308372/d385362d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-308372
- JSON: https://secwatch.observer/filing/0001193125-22-308372.json
- Plain text: https://secwatch.observer/filing/0001193125-22-308372.txt

## Key facts
- Governance Changes
  HCA Healthcare, Inc.: Amended and restated bylaws to revise director nomination and proxy solicitation requirements, including compliance with Rule 14a-19, and incorporate technical conforming changes (effective 2022-12-19).
  - Change: bylaw amendment
  - Effective: 2022-12-19
  source text: On December 19, 2022, the Board of Directors (the “Board”) of HCA Healthcare, Inc. (the “Company”), based on the recommendation of the Nominating and Corporate Governance Committee of the Board, adopted an amendment and restatement of the Company’s Second Amended and Restated Bylaws (as so amended, the “Third Amended Bylaws”), which became effective immediately upon adoption by the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/860730/000119312522308372/0001193125-22-308372-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.